Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

16.7%

2 terminated/withdrawn out of 12 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (12)

Showing 12 of 12 trials
NCT02278666Completed

Minimally Invasive Versus Conventional Aortic Valve Replacement: a Long Term Registry

Role: collaborator

NCT01805466Not ApplicableCompleted

Effects on Organ Damage and Surgical Outcome of a New Cardiopulmonary Pass System (EVADO)

Role: collaborator

NCT01924377Not ApplicableWithdrawn

Characterization and Elimination of Mother Rotors

Role: collaborator

NCT03278418Not ApplicableUnknown

Echo-Guided Tricuspid Valve Surgery Vs. Conservative Approach

Role: lead

NCT03129737Not ApplicableUnknown

PROphylactic triCuspID Annuloplasty in Patients With Dilated Tricuspid Annulus

Role: lead

NCT03190096Unknown

Safety and Feasibility of Electrical Isolation of the Superior Vena Cava for Paroxysmal Atrial Fibrillation

Role: lead

NCT03129750Unknown

Safety and Efficacy of DCB for the Treatment of SFA Ischemic Vascular Disease in Patients With TASC C and D Lesions

Role: lead

NCT01262443Not ApplicableCompleted

Efficacy of Transcatheter Radiofrequency Ablation of Atrial Flutter With Standard Irrigated Catheter With Flexible Tip

Role: lead

NCT01443754Terminated

Hybrid Revascularisation by Combined Coronary Artery Bypass Graft (CABG) and PCI in Multivessel Coronary Disease

Role: lead

NCT01658540Completed

Drug Eluting Balloon (DEB) and Long Lesions of Superficial Femoral Artery (SFA) Ischemic Vascular Disease

Role: lead

NCT01397357Completed

Cardiac Magnetic Resonance Utilities in the Evaluation of Ischemic Heart Disease

Role: lead

NCT01554878Completed

Observational Study on the Treatment of Knee Osteochondral Lesions of Grade III-IV

Role: lead

All 12 trials loaded